Smart Trade Insights
  • Business
  • Economy
  • Investing
  • Politics
Top Posts
New Found Gold Grade Control Drilling Continues to...
Closing date for director nominations
Allied Critical Metals Delivers Robust Initial PEA at...
With Step-Out Drilling Continuing, Radisson Demonstrates Meaningful Resource...
Crypto Market Update: Iran Conflict Pushes Bitcoin Further...
Bold Ventures Provides Update on Burchell Drilling Progress...
Bold Ventures Signs Agreement to Acquire 6 Key...
Sirios Completes Acquisition Of OVI Mining Corp
US-Iran Tensions Put Europe’s Gas Storage Plans at...
Lahontan Gold Eyes Resource Update as Production Nears
  • Business
  • Economy
  • Investing
  • Politics

Smart Trade Insights

Business

DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

by admin January 20, 2025
January 20, 2025
DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

The Department of Justice said Friday that it sued pharmacy giant Walgreens over allegedly dispensing millions of unlawful prescriptions.

The DOJ said that Walgreens from August 2012 until the present “knowingly” filled those prescriptions, which “lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice.” 

“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.

Boynton said that Walgreens pharmacists filled millions of prescriptions with “clear red flags that indicated the prescriptions were highly likely to be unlawful.”

The company “systematically pressured its pharmacists to fill prescriptions, including controlled substance prescriptions, without taking the time needed to confirm their validity,” Boynton said. “These practices allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores.”

Some Walgreens patients died of overdose deaths shortly after getting invalid prescriptions filled at Walgreens, the DOJ alleges.

The 300-page lawsuit was filed Thursday in U.S. District Court in Chicago.

Walgreens in a statement said, “We are asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary ‘rules’ that do not appear in any law or regulation and never went through any official rulemaking process.”

“We will not stand by and allow the government to put our pharmacists in a no-win situation, trying to comply with ‘rules’ that simply do not exist,” Walgreens said.

“Walgreens stands behind our pharmacists, dedicated healthcare professionals who live in the communities they serve, filling legitimate prescriptions for FDA-approved medications written by DEA-licensed prescribers in accordance with all applicable laws and regulations.”

The suit alleges that although Walgreens issued written policies that reflected its understanding of legal obligations, the company took other actions which it knew prevented its pharmacists from complying with them.

“Walgreens prioritized profits over safety and compliance by implementing policies and practices that required pharmacists to fill prescriptions quickly and left pharmacists without enough time or resources to exercise their corresponding responsibility,” the suit said.

“One such metric was ‘Verify By Promise Time’ (VBPT), which expected a pharmacist to fill a prescription within 15 minutes for a ‘waiter’ (a customer waiting in the pharmacy store for the prescription),” the suit alleges.

“Walgreens also tracked pharmacists that dispensed a low rate of controlled substances through its ‘Non-dispensing Pharmacist Report,’” the suit said.

“Walgreens created this metric in part because it believed pharmacists who refused to fill controlled-substance prescriptions compromised Walgreens’s customer service.”

This post appeared first on NBC NEWS

previous post
Tech 5: Trump to Prioritize Crypto, Biden Blocks AI Chip Exports
next post
S&P 500 climbed 0.3%, and Nasdaq-100 futures jumped 0.7%

You may also like

How sustainable diaper brand Kudos is taking on...

August 7, 2024

Bargain hunters drive Walmart sales and outlook higher

November 22, 2025

Target calls price hikes a ‘very last resort’...

May 22, 2025

U.S. added 818,000 fewer jobs than thought, adding...

August 23, 2024

Meta announces end of its DEI programs. Read...

January 12, 2025

Macy’s says employee hid up to $154 million...

November 26, 2024

Tesla agrees to first deal to build China’s...

June 22, 2025

SEC charges Carl Icahn with hiding billions of...

August 21, 2024

All major Las Vegas Strip casinos are now...

August 5, 2025

Google loses antitrust case over search

August 7, 2024

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • New Found Gold Grade Control Drilling Continues to Deliver At-Surface High Grade Gold over Broad Widths at Queensway:

      March 2, 2026
    • Closing date for director nominations

      March 2, 2026
    • Allied Critical Metals Delivers Robust Initial PEA at the Borralha Project

      March 2, 2026
    • With Step-Out Drilling Continuing, Radisson Demonstrates Meaningful Resource Growth at O’Brien with an Updated Mineral Resource Estimate

      March 2, 2026
    • Crypto Market Update: Iran Conflict Pushes Bitcoin Further Under US$67K

      March 2, 2026
    Promotion Image

    banner ads

    Categories

    • Business (941)
    • Economy (839)
    • Investing (4,003)
    • Politics (747)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smarttradeinsights.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 smarttradeinsights.com | All Rights Reserved